Home
>
National Drug Code (NDC)
>
Sonata
Sonata - 60793-145-01 - (ZALEPLON)
Drug Information of Sonata
| Product NDC: | 60793-145 |
| Proprietary Name: | Sonata |
| Non Proprietary Name: | ZALEPLON |
| Active Ingredient(s): | 5 mg/1 & nbsp; ZALEPLON |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Sonata
| Product NDC: | 60793-145 |
| Labeler Name: | King Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020859 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990813 |
Package Information of Sonata
| Package NDC: | 60793-145-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (60793-145-01) |
NDC Information of Sonata
| NDC Code | 60793-145-01 |
| Proprietary Name | Sonata |
| Package Description | 100 CAPSULE in 1 BOTTLE (60793-145-01) |
| Product NDC | 60793-145 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ZALEPLON |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19990813 |
| Marketing Category Name | NDA |
| Labeler Name | King Pharmaceuticals, Inc. |
| Substance Name | ZALEPLON |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE] |
